Total Assets for Abbott Laboratories (ABT)
According to Abbott Laboratories's latest reported financial statements, the company's latest reported total assets is $86.71B USD. Total assets sum everything the company reports owning at the end of each reporting period — cash, receivables, inventory, property, plant, equipment, intangibles, and other holdings — as filed on the balance sheet. Compare with total liabilities and net assets for the capital-structure picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingTotal AssetsSwitch metric
Latest period
$86.71B
YoY change
+6.5%
5Y CAGR
+3.6%
Peak year (2025)
$86.71B
Latest annual
$86.71B
Total Assets history chart for Abbott Laboratories (ABT) from 1985 to 2025
Total Assets history table for Abbott Laboratories (ABT) from 1985 to 2025
| Fiscal year | Period ended | Reported | Total Assets | YoY |
|---|---|---|---|---|
| 2025 | $86.71B | +6.5% | ||
| 2024 | $81.41B | +11.2% | ||
| 2023 | $73.21B | -1.6% | ||
| 2022 | $74.44B | -1.0% | ||
| 2021 | $75.20B | +3.6% | ||
| 2020 | $72.55B | +6.9% | ||
| 2019 | $67.89B | +1.1% | ||
| 2018 | $67.17B | -11.9% | ||
| 2017 | $76.25B | +38.6% | ||
| 2016 | $55.01B | +25.0% | ||
| 2015 | $44.00B | +0.5% | ||
| 2014 | $43.79B | +2.0% | ||
| 2013 | $42.95B | -36.1% | ||
| 2012 | $67.23B | +11.5% | ||
| 2011 | $60.28B | -0.5% | ||
| 2010 | $60.57B | +15.2% | ||
| 2009 | $52.58B | +24.0% | ||
| 2008 | $42.42B | +6.8% | ||
| 2007 | $39.71B | +9.8% | ||
| 2006 | $36.18B | +24.1% | ||
| 2005 | $29.14B | +1.3% | ||
| 2004 | $28.77B | +7.7% | ||
| 2003 | $26.72B | +10.1% | ||
| 2002 | $24.26B | +4.1% | ||
| 2001 | $23.30B | +52.4% | ||
| 2000 | $15.28B | +5.6% | ||
| 1999 | $14.47B | +9.5% | ||
| 1998 | $13.22B | +9.6% | ||
| 1997 | $12.06B | +8.4% | ||
| 1996 | $11.13B | +18.2% | ||
| 1995 | $9.41B | +10.4% | ||
| 1994 | $8.52B | +10.9% | ||
| 1993 | $7.69B | +10.8% | ||
| 1992 | $6.94B | +11.0% | ||
| 1991 | $6.26B | +12.4% | ||
| 1990 | $5.56B | +14.7% | ||
| 1989 | $4.85B | +0.5% | ||
| 1988 | $4.83B | +10.0% | ||
| 1987 | $4.39B | +13.5% | ||
| 1986 | $3.87B | +11.5% | ||
| 1985 | $3.47B | — |
Total Assets values are taken from Abbott Laboratories's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
Abbott Laboratories (ABT) most recent annual total assets stands at $86.71B (2025) – grew 6.5% year-over-year.
Abbott Laboratories total assets has grown for 2 consecutive years, with a +3.6% compound annual growth rate over 2020–2025 (5 years).
2025 marks the peak total assets at $86.71B, with the historical low of $3.47B recorded in 1985.
Among 8 Healthcare peers, Abbott Laboratories (ABT) ranks 9th; the peer median for total assets is $135.41B.
Abbott Laboratories Total Assets by Year
Abbott Laboratories Total Assets 2025: $86.71B
Abbott Laboratories total assets in 2025 was $86.71B, grew 6.5% from 2024. This figure represents the highest annual value in the available history.
Abbott Laboratories Total Assets 2024: $81.41B
Abbott Laboratories total assets in 2024 was $81.41B, grew 11.2% from 2023.
Abbott Laboratories Total Assets 2023: $73.21B
Abbott Laboratories total assets in 2023 was $73.21B, edged down 1.6% below 2022.
Abbott Laboratories Total Assets 2022: $74.44B
Abbott Laboratories total assets in 2022 was $74.44B, edged down 1.0% below 2021.
Abbott Laboratories Total Assets 2021: $75.20B
Abbott Laboratories total assets in 2021 was $75.20B.
See more financial history for Abbott Laboratories (ABT).
Sector peers — Total Assets
Companies in the same sector as Abbott Laboratories, ranked by their latest total assets.
| Company | Total Assets | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $542.90B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $309.58B | Healthcare |
| Johnson & Johnson (JNJ) | $199.21B | Healthcare |
| Merck & Co., Inc. (MRK) | $136.87B | Healthcare |
| AbbVie Inc. (ABBV) | $133.96B | Healthcare |
| AstraZeneca PLC (AZN) | $114.07B | Healthcare |
| Eli Lilly and Company (LLY) | $112.48B | Healthcare |
| Amgen Inc. (AMGN) | $90.59B | Healthcare |
Frequently asked questions
What is Abbott Laboratories's total assets?
- Latest reported total assets for Abbott Laboratories (ABT) is $86.71B (period ending December 31, 2025).
How has Abbott Laboratories total assets changed year-over-year?
- Abbott Laboratories (ABT) total assets changed +6.5% year-over-year on the latest annual filing.
What is the long-term growth rate of Abbott Laboratories total assets?
- Abbott Laboratories (ABT) total assets compound annual growth rate is +3.6% over the most recent 5 years available.
When did Abbott Laboratories total assets hit its highest annual value?
- Abbott Laboratories total assets reached its highest annual value of $86.71B in 2025.
What was Abbott Laboratories total assets in 2024?
- Abbott Laboratories (ABT) total assets in 2024 was $81.41B.
What was Abbott Laboratories total assets in 2025?
- Abbott Laboratories (ABT) total assets in 2025 was $86.71B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
ABT Overview
Company profile, financial tools, and key metrics
ABT Revenue Counter
Earns $1,431 every second. See per minute, hour, and day.
ABT Earnings Counter
Earns $199.01 per second net profit. See per minute, hour, and day.
ABT Economic Scale
Exceeds Paraguay's GDP. Compare with world economies.
ABT What If Invested
What if you had invested $1,000? See historical returns from any date.
ABT How It Makes Money
Discover visual breakdown of $45.13B in revenue — where it comes from and where it goes.
ABT Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
ABT Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
ABT Daily Price Character
Steady · 48.2% historical win rate (green days). Streaks & record days.
ABT Buybacks
0.41% TTM buyback yield. Shareholder yield & SBC comparison.
ABT Stock Split History
9 splits on record. Dates, ratios, and cumulative multiple.
ABT Dividend Profile
Yield: 2.67%. Safety: 6/8. See full history.
ABT Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
ABT Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.